• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
    • Sports
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • Trump Administration
  • IN FOCUS
  • Opinion
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Pharmaceutical Industry

    Tag: Pharmaceutical Industry

    FDA rejects wider use of J&J Xarelto for 3rd time
    Business

    FDA rejects wider use of J&J Xarelto for 3rd time

    Washington Examiner -
    February 14, 2014 5:46 pm
    0
    FILE - In this Tuesday, Dec. 21, 2004, file photo, several Aleve tablets appear in front of bottles of the pain reliever, in Boston.  Federal health experts are taking a second look this week at the heart safety of pain medications used by millions of Americans to treat arthritis and other everyday aches and pains. (AP Photo/Steven Senne, File)
    Business

    FDA reconsiders heart safety of common pain pills

    Matthew Perrone -
    February 10, 2014 9:36 pm
    0
    GlaxoSmithKline profits nearly triple in Q4
    Business

    GlaxoSmithKline profits nearly triple in Q4

    Washington Examiner -
    February 5, 2014 5:14 pm
    0
    In this Thursday, Feb. 28, 2013 photo, a Merck logo is placed on scientist's lab coat in West Point, Pa. Merck & Co. reports quarterly financial results before the market opens on Wednesday, Feb. 5, 2014. (AP Photo/Matt Rourke)
    Business

    Merck Q4 net drops 14 pct. on generic competition

    Linda Johnson -
    February 5, 2014 4:25 pm
    0
    FDA clears first drug for blindness sleep disorder
    Business

    FDA clears first drug for blindness sleep disorder

    Washington Examiner -
    January 31, 2014 9:51 pm
    0
    Lilly 4Q profit falls 12 pct, hurt by patent loss
    Business

    Lilly 4Q profit falls 12 pct, hurt by patent loss

    Washington Examiner -
    January 30, 2014 12:45 pm
    0
    Stocks rise on Wall Street after 3 days of losses
    Business

    Stocks rise on Wall Street after 3 days of losses

    Steve Rothwell -
    January 28, 2014 10:31 pm
    0
    Recently, the FDA fast-tracked approval of a vaccine for the influenza strain H5N1, even though there had not yet been reported cases of H5N1, and the vaccine had been subjected to significantly less clinical research than the meningitis B vaccine. (Thinkstock)
    Healthcare

    FDA bureaucracy stifles access to life-saving drugs

    Erik Telford -
    January 23, 2014 5:00 am
    0
    FDA panel again rejects wider use of J&J’s Xarelto
    Healthcare

    FDA panel again rejects wider use of J&J’s Xarelto

    Washington Examiner -
    January 16, 2014 9:38 pm
    0
    Studies show not taking medications as prescribed leads to poorer health, more frequent hospitalization, a higher risk of death and as much as $290 billion annually in increased medical costs. But as any health care provider will tell you, the fact that actually taking a medication as prescribed is in a patient’s best interest does not lead to a patient doing what is in his best interest. (Photo: Thinkstock)
    Op-Eds

    Grandstanding AGs sue to stop drugmaker’s work to insure patients take medicine properly

    Peter Pitts -
    January 14, 2014 5:00 am
    0
    1...151152153154Page 152 of 154
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter